| Bioactivity | CDK-TCIP1 is a bivalent molecule linking CDK9 inhibitor SNS-032 (HY-10008) to BCL6 ligand BI3812 (HY-111381). CDK-TCIP1 potently and specifically kills BCL6-overexpressing cells with EC50 of 7.7 nM for SUDHL5 cells[1]. |
| CAS | 3008612-35-6 |
| Formula | C48H62ClN11O8S2 |
| Molar Mass | 1020.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Roman C Sarott, et al. Relocalizing transcriptional kinases to activate apoptosis. Science. 2024 Oct 4;386(6717):eadl5361. |
CDK-TCIP1
CAS: 3008612-35-6 F: C48H62ClN11O8S2 W: 1020.66
CDK-TCIP1 is a bivalent molecule linking CDK9 inhibitor SNS-032 (HY-10008) to BCL6 ligand BI3812 (HY-111381). CDK-TCIP1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.